大族数控 reported revenue of ¥4.98B for the period ended 2026-06-30, +109.3% year on year. Net income was ¥0.97B, a 19.4% net margin on a 35.1% gross margin. The largest revenue line is 钻孔类设备 at 73% of the total. Free cash flow for the period was ¥-0.49B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥4.98B | +109.3% |
| Gross profit | ¥1.75B | — |
| Operating income | ¥1.11B | — |
| Net income | ¥0.97B | +270.6% |
| Gross margin | 35.1% | Net margin 19.4% |
| Revenue Q/Q | +55.0% | — |
| Segment | Revenue | Share |
|---|---|---|
| 钻孔类设备 | ¥3.62B | 72.6% |
| 检测类设备 | ¥0.42B | 8.4% |
| 成型类设备 | ¥0.40B | 7.9% |
| 曝光类设备 | ¥0.30B | 6.0% |
| 其他(补充) | ¥0.16B | 3.3% |
| 贴附类设备 | ¥0.07B | 1.4% |
| 压合类设备 | ¥0.02B | 0.4% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥3.23B | 64.9% |
| R&D | ¥0.27B | 5.4% |
| SG&A | ¥0.37B | 7.5% |
| Tax & other | ¥0.14B | 2.9% |
| Item | Amount |
|---|---|
| Total assets | ¥18.20B |
| Total liabilities | ¥6.13B |
| Shareholders' equity | ¥12.07B |
| Equity / assets | 66.3% |
| Operating cash flow | ¥-0.43B |
| Capital expenditure | ¥0.06B |
| Free cash flow | ¥-0.49B |
| Cash conversion (OCF / net income) | -111% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
诚达药业 ・ 朗威股份 ・ 国泰环保 ・ 联特科技 ・ 三元生物 ・ 华兰疫苗 ・ 中亦科技 ・ 联合化学 ・ 金杨精密 ・ 亨迪药业 ・ 联盛化学 ・ 观想科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies